Fairview Capital Investment Management, LLC Bristol Myers Squibb CO Transaction History

Fairview Capital Investment Management, LLC

$1.67 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $5,913 - $6,707	-90 Reduced 1.77%	5,000 $346,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $6,848 - $8,109	-100 Reduced 1.93%	5,090 $366,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $13 - $7,684	100 Added 1.96%	5,190 $368,000
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $369,635 - $407,098	5,090 New	5,090 $391,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.2 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.4 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.51 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.62 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.62 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.

Account